Pamela Kaye Footman

Title: **Pamela Kaye Footman: Innovator in Pharmaceutical Crystallization**

Introduction

Pamela Kaye Footman, based in Indianapolis, IN, is a talented inventor contributing to the pharmaceutical field through her innovative work in crystallization. With a focus on novel chemical compounds, her research plays a significant role in advancing medical treatments and therapies.

Latest Patents

Footman holds a patent for her invention titled "Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone." This patent describes the development of new crystalline forms, compositions, intermediates, and methods of use related to the chemical compound, which may provide significant benefits in pharmaceutical applications.

Career Highlights

Throughout her career, Pamela Kaye Footman has made substantial contributions while working at Eli Lilly and Company. Her expertise in the field of pharmaceutical sciences and her pioneering work on crystalline forms of complex chemical compounds have earned her recognition and respect in the industry.

Collaborations

In her capacity at Eli Lilly, Footman has collaborated with notable colleagues such as Alfio Borghese and David Scott Coffey. Their teamwork exemplifies the collaborative spirit essential for pushing forward innovative research and development in the pharmaceutical sector.

Conclusion

Pamela Kaye Footman's inventive contributions continue to influence the pharmaceutical landscape, particularly through her innovative developments in crystallization. Her dedication to advancing the science of medicine is evident in her patent and the collaborative efforts with her esteemed colleagues.